Investigating the longitudinal relationship between alcohol use, neurophysiological functioning, and Alzheimer disease biomarkers in the Collaborative Study on the Genetics of Alcoholism
Project Number5R01AA029308-05
Former Number1R01AG070992-01
Contact PI/Project LeaderHARTZ, SARAH
Awardee OrganizationWASHINGTON UNIVERSITY
Description
Abstract Text
Project Summary
This is a study to investigate the relationship between trajectories of alcohol use, longitudinal changes in brain
function, and the development of Alzheimer disease (AD). To address gaps in knowledge about the
relationship between alcohol use and AD, we will integrate plasma Aβ testing and a measurement of clinical
dementia into ongoing assessments of N=600 participants (age ≥ 50, 17% African American) in a large
ongoing study of alcohol use disorder. We will leverage sample collection from the St. Louis site of the
Collaborative Study on the Genetics of Alcoholism (COGA), a longitudinal, family-based study of alcohol use
disorder funded by NIAAA for over 30 years, with extensive clinical, neuropsychological, electrophysiological,
and genetic data from families densely affected by alcohol use disorder and community-based comparison
families. The ongoing assessments of older COGA participants includes a comprehensive evaluation of alcohol
use, neurophysiological measures including resting-state electroencephalogram (EEG) and event-related brain
potentials (ERPs) acquired during cognitive tasks (same as in previous longitudinal assessments), and
neuropsychological surveys. Together with existing COGA data, the new combined assessment will allow for
creation of powerful measures of alcohol use, brain function, and neuropathology.
This represents the first study to integrate AD biomarkers with comprehensive, longitudinal assessments of
alcohol use. Aim 1 will examine the effect of alcohol consumption on preclinical AD and longitudinal changes in
brain function and cognition in older adults. Aim 2 will investigate genetic, comorbid, environmental, and
demographic factors as moderating the effect of alcohol consumption on AD biomarkers and brain function.
The innovations include integration of state-of-the-art AD assessment, plasma biomarker of AD, brain function
measures of neural synchronicity and connectivity, and comprehensive longitudinal assessment of alcohol use
in a high-risk sample that has been followed over 20 years. This proposal is significant because the products
and results will apply broadly to our understanding of both the development of AD and the long-term impact of
alcohol on the brain.
Public Health Relevance Statement
Relevance to Public Health
This project will recruit adults age 50 and older from an existing long-term study of alcohol use disorder to
examine the relationship between alcohol use, aging brain function, and Alzheimer disease. This may help
researchers develop treatments and ultimately reduce illness and mortality.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAdultAffectAfrican AmericanAgeAlcohol consumptionAlcoholic beverage heavy drinkerAlcoholsAllelesAlzheimer disease detectionAlzheimer's DiseaseAlzheimer's disease riskAlzheimer’s disease biomarkerAmyloid beta-ProteinApolipoprotein EAuditoryBlood TestsBrainBrain PathologyBrain regionClinicalCognitionCommunitiesComplexDataDementiaDemographic FactorsDevelopmentDiseaseEducationElectroencephalographyElectrophysiology (science)Environmental Risk FactorEvaluationEventFamilyFundingGenesGeneticHeavy DrinkingImpaired cognitionKnowledgeLightLongitudinal StudiesMeasurementMeasuresNational Institute on Alcohol Abuse and AlcoholismNerve DegenerationNeuropsychologyOnset of illnessParticipantPatternPhasePlasmaProcessPsychopathologyPublic HealthResearch PersonnelRestSamplingSemanticsSiteSpan 20SurveysTestingVisualabeta depositionage relatedage related declineaging brainalcohol effectalcohol use disordercognitive taskcomorbiditydemographicsdesigndrinkinggenetic risk factorgenetics of alcoholismhigh riskimaging studyinnovationinsightmembermortalityneuralneural networkneuropathologyneurophysiologyneurotoxicolder adultpolygenic risk scorepre-clinicalprotective factorsrecruitsample collectionstructural imagingsubstance use
National Institute on Alcohol Abuse and Alcoholism
CFDA Code
273
DUNS Number
068552207
UEI
L6NFUM28LQM5
Project Start Date
20-September-2020
Project End Date
30-June-2025
Budget Start Date
01-July-2024
Budget End Date
30-June-2025
Project Funding Information for 2024
Total Funding
$393,750
Direct Costs
$250,000
Indirect Costs
$143,750
Year
Funding IC
FY Total Cost by IC
2024
National Institute on Alcohol Abuse and Alcoholism
$393,750
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AA029308-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AA029308-05
Patents
No Patents information available for 5R01AA029308-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AA029308-05
Clinical Studies
No Clinical Studies information available for 5R01AA029308-05
News and More
Related News Releases
No news release information available for 5R01AA029308-05
History
No Historical information available for 5R01AA029308-05
Similar Projects
No Similar Projects information available for 5R01AA029308-05